Literature DB >> 11429060

Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumor cells.

T Takechi1, K Koizumi, H Tsujimoto, M Fukushima.   

Abstract

To identify genes differentially expressed in association with resistance to 5-fluorouracil (5FU), an mRNA differential display (DD) analysis was used to compare transcripts from the NUGC-3 human gastric tumor cell line and the NUGC-3 / 5FU / L line, which had acquired 208-fold resistance as a consequence of repeated exposure to escalating concentrations of 5FU. The 110 cDNA fragments differentially expressed in the DD analysis of either the NUGC-3 or NUGC-3 / 5FU / L cells were sequenced and subjected to a homology search, and 29 overexpressed and 22 underexpressed genes were identified in NUGC-3 / 5FU / L as a result. To confirm whether the changes in the gene expression levels in the NUGC-3 / 5FU / L cells were shared by other 5FU-resistant cells, 35 genes were analyzed by northern hybridization in 3 pairs of parent / 5FU-resistant human gastrointestinal tumor cell lines. The analysis revealed 20 overexpressed and 10 underexpressed genes in at least one of the three 5FU-resistant cells as compared with those in the parent cells. Among them, P-glycoprotein, equilibrative nucleoside transporter 1, and methylenetetrahydrofolate dehydrogenase were highly expressed in two of the three 5FU-resistant cells and cytidine deaminase and integrin alpha3 were underexpressed. The acquisition of resistance to 5FU by tumor cells may result from multiple changes in cellular functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429060      PMCID: PMC5926762          DOI: 10.1111/j.1349-7006.2001.tb01150.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


DNA ligase III poly(ADP‐ribose) polymerase glucose transporter NAD(P) trans‐hydrogenase dihydropyrimidine dehydrogenase thy‐midine kinase thymidine phosphorylase ribonucle‐oside‐diphosphate reductase M1 subunit ribonucleoside‐diphosphate reductase M2 subunit topoisomerase 1 topoisomerase 2α topoisomerase 2β DNA excision repair protein ERCC1 uracil‐DNA glyco‐sylase multidrug resistance‐associated protein 1 equilibrative nucleoside transporter 2 vascular endo‐thelial growth factor β
  22 in total

1.  Interaction of 2',2'-difluorodeoxycytidine (gemcitabine) and formycin B with the Na+-dependent and -independent nucleoside transporters of Ehrlich ascites tumor cells.

Authors:  T Burke; S Lee; P J Ferguson; J R Hammond
Journal:  J Pharmacol Exp Ther       Date:  1998-09       Impact factor: 4.030

2.  Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs.

Authors:  M Griffiths; N Beaumont; S Y Yao; M Sundaram; C E Boumah; A Davies; F Y Kwong; I Coe; C E Cass; J D Young; S A Baldwin
Journal:  Nat Med       Date:  1997-01       Impact factor: 53.440

3.  Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27.

Authors:  C Garrido; P Mehlen; A Fromentin; A Hammann; M Assem; A P Arrigo; B Chauffert
Journal:  Eur J Biochem       Date:  1996-05-01

Review 4.  Resistance to 5-fluorouracil.

Authors:  R M Mader; M Müller; G G Steger
Journal:  Gen Pharmacol       Date:  1998-11

5.  Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.

Authors:  C Aschele; A Sobrero; M A Faderan; J R Bertino
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

6.  Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.

Authors:  S Copur; K Aiba; J C Drake; C J Allegra; E Chu
Journal:  Biochem Pharmacol       Date:  1995-05-17       Impact factor: 5.858

7.  Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein.

Authors:  J Huot; G Roy; H Lambert; P Chrétien; J Landry
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

8.  Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

Authors:  J R Mackey; R S Mani; M Selner; D Mowles; J D Young; J A Belt; C R Crawford; C E Cass
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

Review 9.  Folic acid metabolism and its disruption by pharmacologic agents.

Authors:  F M Huennekens; T H Duffy; K S Vitols
Journal:  NCI Monogr       Date:  1987

10.  Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.

Authors:  M Inaba; J Mitsuhashi; H Sawada; N Miike; Y Naoe; A Daimon; K Koizumi; H Tsujimoto; M Fukushima
Journal:  Jpn J Cancer Res       Date:  1996-02
View more
  5 in total

1.  Synergistic antitumor effect of combined 5-fluorouracil (5-FU) with 5-chloro-2,4-dihydroxypyridine on 5-FU-resistant gastric cancer cells: possible role of a dihydropyrimidine dehydrogenase-independent mechanism.

Authors:  Eiji Sasaki; Kazunari Tominaga; Hikaru Kuwamura; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Kazuhide Higuchi; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

2.  The Promise of Integrins as Effective Targets for Anticancer Agents.

Authors:  William L. Rust; Stephen W. Carper; George E. Plopper
Journal:  J Biomed Biotechnol       Date:  2002

3.  Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.

Authors:  Yongkuan Cao; Guohu Zhang; Peihong Wang; Jun Zhou; Wei Gan; Yaning Song; Ling Huang; Ya Zhang; Guode Luo; Jiaqing Gong; Lin Zhang
Journal:  BMC Gastroenterol       Date:  2017-01-05       Impact factor: 3.067

Review 4.  Equilibrative Nucleoside Transporter 2: Properties and Physiological Roles.

Authors:  Safaa M Naes; Sharaniza Ab-Rahim; Musalmah Mazlan; Amirah Abdul Rahman
Journal:  Biomed Res Int       Date:  2020-12-03       Impact factor: 3.411

5.  Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase.

Authors:  Ayako Nakamura; Go Nakajima; Ryuji Okuyama; Hidekazu Kuramochi; Yurin Kondoh; Toshinori Kanemura; Teiji Takechi; Masakazu Yamamoto; Kazuhiko Hayashi
Journal:  Gastric Cancer       Date:  2013-03-15       Impact factor: 7.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.